Research Brief: Did γ-Secretase Mutation Get Under Karl Marx’s Skin?
Could it be that a γ-secretase mutation helped give rise to communism?
ALL NEWS
124 RESULTS
Sort By:
- Most Recent
- Most Commented
DIAN Dispatch from Hawaii: Glimpse at Data, Push for Trials
Leaders of DIAN gathered to brief each other to present to some 30 pharmaceutical industry scientists the first cut of baseline data from this ongoing biomarker study...
DIAN Dispatch From Hawaii: After Slow Start, Network Is Humming
After more than a year of rumbling to life, the Dominantly Inherited Alzheimer’s Network (DIAN) has kicked into gear and is now enrolling research participants at a healthy clip...
News Flash: The New York Times Covers Colombian Family, API
In a sign that prevention trials are shifting from “should do” to “will do,” academic and industry groups are getting serious about prevention trials...
Research Brief: Auguste D.'s Mutation Identified?
Scientists propose that Auguste Deter, the first identified Alzheimer disease patient, carried the N141I presenilin-2 mutation...
Phoenix: Trials in Colombia and the U.S. for Those at Highest Risk?
Researchers have laid out a vision for pre-symptomatic treatment trials that emphasize use of biomarkers to evaluate investigational drugs...
Phoenix: Can Alzheimer’s Prevention Initiative Break a Catch-22?
The Alzheimer’s Prevention Initiative is a proposal to get serious about Alzheimer disease prevention research...
Phoenix: Vision of Shared Prevention Trials Lures Pharma to Table
On 26 January 2010, at an ordinary airport hotel in Phoenix, Arizona, an extraordinary gathering unfolded...
ARF Notable Book: The Thousand Mile Stare, by Gary Reiswig
Through their research participation, the Reiswig extended family made possible the identification of presenilin 2 on chromosome 1...
St. Louis: An eFAD Prevention Trial—One Man’s View
DIAN was founded with the hope that its participating families could be offered a prevention trial and/or treatment trial before too long...
St. Louis: Is Rare Familial Alzheimer’s a Model for the Millions?
One question that pervaded the 7th Leonard Berg Symposium is whether dominantly inherited Alzheimer disease really is the same disease as the common late-onset forms...
St. Louis: Biomarkers Pre-dementia—Like eFAD, Like LOAD?
As throughout this conference, talks toggled between what’s known in LOAD and eFAD, comparing all the while how well knowledge on these forms of AD matches up...
St. Louis: Cognition Pre-dementia—Like eFAD, Like LOAD?
At the 7th Leonard Berg Symposium scientists and patient advocates came together to exchange the latest news on detecting disease presymptomatically...
St. Louis: The Family View—What Do Study Volunteers Want From DIAN?
When do researchers get to hear from study participants how deeply their families have struggled for decades and what kinds of services would make studies worth their while?...
St. Louis: Scientists, Families Target Preclinical Detection, Trials
Earlier this month, researchers met to devote two intense days of talks and discussion to their goal of presymptomatic detection of Alzheimer disease...
Current Filters
- Early Onset AD x